While it may seem strange that politics could impact the price of popular weight loss drugs, it is a definite possibility.

Alguns pacientes que fizeram uso de medicamentos para perda de peso, como Ozempic e Wegovy, desenvolveram problemas de visão.

Nephrologists jumped on the GLP-1 bandwagon well before Novo Nordisk won FDA approval for Ozempic in chronic kidney disease ...

O medicamento estrela para a diabetes e muito utilizado para a obesidade, Ozempic, vale quase metade da faturação da Novo Nordisk.

Scientists remain puzzled as to why some individuals taking popular weight loss and diabetes medications such as Ozempic and ...

Ozempic has been approved to reduce the risk of worsening kidney disease and cardiovascular death in adults with Type 2 ...

Chief executive Emma Walmsley said ministers must work with the sector to boost investment amid growing concerns about doing ...

Eli Lilly and Novo Nordisk have both assuaged investor concerns over near-term growth. Now the focus shifts back to their ...